微創機器人-B(02252.HK):圖邁遠程手術全科室應用獲得國家藥品監督管理局註冊批準
格隆匯4月23日丨微創機器人-B(02252.HK)公告,集團自主研發的圖邁®腔鏡手術機器人遠程手術全科室應用獲得國家藥品監督管理局(NMPA)的註冊批準,成爲全球首個獲批可應用於全科室遠程手術的腔鏡手術機器人。遠程手術技術,是公司多年來持續攻克並重點研發的方向之一,是對公司「讓天下沒有難做的手術」初心的踐行。
本次圖邁遠程獲得NMPA批準,是引領全球機器人領域技術與應用發展的里程碑式突破,將開啓全球遠程外科產業化新篇章,標誌着全球外科手術正式進入遠程手術時代。同時,圖邁遠程的獲證將使集團的產品組合進一步豐富和多元,圖邁系列機器人已實現多孔、單孔、遠程一體化兼容,可爲醫院和醫生提供腔鏡手術機器人系統智能化全解方案,將有助於提升集團機器人產品組合在全球市場的競爭力。
據悉,圖邁遠程爲公司核心產品圖邁腔鏡手術機器人的遠程手術系統應用,全球首創技術可兼容多種通訊網絡,具有低延時主從控制、高帶寬網絡通訊及高穩定性系統架構設計等方面的技術優勢。集團於業內首次提出「第二代遠程手術」技術理念,即兼容5G和醫院常規網絡的多網融會技術,不依賴專線或單一供應商,低成本實現一對多,多對多的遠程互聯與控制,不斷引領全球遠程外科創新與臨牀應用。
自2022年6月實施全球首例5G超遠程手術以來,圖邁遠程在亞洲、美洲、非洲多個國家的多種地形、海洋環境、多種氣候條件下,以5G專線、5G網絡、寬帶網絡、地球同步軌道衛星等多種通信技術,輔助國內外專家完成覆蓋50多個城市,80多家醫院的多科室遠程手術近400例,累計通信距離接近800,000公里,實施成功率達100%,創造了40餘項全國乃至世界紀錄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.